0
You have 0 items in your cart

The Liver Summit

Current Event

26Sep

The Liver Summit (TLS 2026)

7:45 am - 5:00 pmDelta Marriott

Directors

Thomas G. Cotter

MD, MS — President

General and transplant hepatologist and obesity medicine specialist who founded Texas Liver Care in 2025 to advance education, outreach, and innovation in liver and metabolic health

Sumeet Asrani

Participating Faculty

Mazen Noureddin

Naim Alkhouri

Juan Pablo Arab

Michael Charlton

Tonia Vinton

Mack Mitchell

Jeremy Louissaint

Ashwini Mehta

Thomas Kerr

Scott Carlson

Ranjeeta Bahirwani

Mohammad Qasim Khan

Mazen Iskandar

Fabrizzio Delgado

Craig Rosenstengle

Ahmad Anouti

Patient Advocacy Director

Biliary atresia liver transplant recipient, physician, researcher, and patient advocate. Manages board communications, governance compliance, and official records, providing unique patient-centered perspectives.

Agenda

Saturday, September 26, 2026

7:45 AM - 8:30 AMBreakfast and Registration - Delta Marriott Foyer

Session 1 - Integrating Metabolic Health in Liver Care (Delta Marriott Conference Room)Moderator: Sumeet Asrani, MD MSc

8:30 AM - 8:55 AMWeight Management in Liver Disease: Diet, Activity, and Obesity PharmacotherapyTonia Vinton, MD

9:55 AM - 9:20 AMEndobariatrics & Bariatric Surgery in the GLP-1 Agonist EraMazen Iskander, MD

9:20 AM - 9:45 AMPractical Management Strategies for Diabetes, Hypertension, and Cardiovascular Risk ReductionScott Carlson, MD

9:45 - 10:10 AM

Metabolic Health After Transplant: Preventing Weight Gain, Diabetes, and Cardiovascular DiseaseMohammad Qasim Khan, MD

10:10 - 10:30 AMPanel Discussion & Q&A

10:30 AM - 10:40 AMCoffee Break  - Foyer

10:40 AM - 11:00 PMLiving the Journey: A Patient's Perspective on Liver DiseaseAhmad Anouti, MD

11:00 AM - 11:30 AMCoffee and Visit Exhibits - Delta Marriott Foyer

11:30 AM - 12:15 PMDelta Marriott Conference RoomIndustry-Supported Educational Symposium (Non-CME)Ashwini Mehta, DO Industry-Sponsored EventSponsored by Madrigal Pharmaceuticals

12:15 PM - 12:45 PMLunch and Visit Exhibits - Delta Marriott Foyer

 

Session 2 - Steatotic Liver Disease - The Clinical Spectrum & Future DirectionsModerator: Mack Mitchell, MD

12:45 PM - 1:10 PMMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Impact & Evolving ConceptsNaim Alkhouri, MD

1:10 PM - 1:35 PMMetabolic Dysfunction-Associated Alcohol-Related Liver Disease (MetALD): Defining the OverlapJuan Pablo Arab MD

1:35 PM - 2:00 PMAlcohol Use Disorder and Disordred Eating in Liver Disease: Clinical Management StrategiesFabrizzio Delgado, MD

2:00 PM - 2:25 PMSteatotic Liver Disease Drug Pipeline: Current Trials and Future HorizonsMichael Charlton, MBBS

2:25 PM - 2:50 PM

How I Treat MASLD and MetALD: A Practical, Case-Based Approach

2:50 PM - 3:10 PMPanel Discussion & Q&A

3:10 PM - 3:20 PMBreak and Visit Exhibits - Foyer

Session 3 - General Hepatology Updates

Moderator: Mohammad Qasim Khan, MD

3:20 PM - 3:40 PMPrimary Biliary Cholangitis and Primary Sclerosing Cholangitis: Diagnosis and Treatment UpdatesAshwini Mehta, DO

3:40 PM - 4:00 PMHepatocellular Carcinoma and Cholangiocarcinoma: Advances in Diagnosis and ManagementCraig Rosenstengle, MD

4:00 PM - 4:20 PMArtificial Intelligence in Liver CareJeremy Louissaint, MD

4:20 PM - 4:40 PMPreventing Cirrhosis Complications: From Anticoagulation to Beta BlockersRanjeeta Bahirwani, MD 4:40 PM - 5:00 PMViral Hepatitis in 2026: Practical Updates in Screening, HBV Management, and Cure PathwaysThomas Kerr, MD

Close at 5:00 PMClosing Remarks and Networking Reception